Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/28/2009CN101564388A Composition for Danshensu and danshinolic acid B and use thereof
10/28/2009CN101564387A Oral arginine ibuprofen liquid preparation
10/28/2009CN101564386A Novel applications of pinane amine as M2 inhibitor in pharmacy
10/28/2009CN101564385A Application of aether in preparing anti-AIDS medicaments
10/28/2009CN101564384A Multivitamin aqueous solution preparation
10/28/2009CN101564382A Iguratimod osmotic pump controlled slow-release preparation
10/28/2009CN101564381A Gemcitabine hydrochloride lyophilized powder injection
10/28/2009CN101564379A Methazolamide lipidosome and manufacture method thereof
10/28/2009CN101564378A Levocarnitine oral solution and preparation method thereof
10/28/2009CN101564377A Oxybutynin transdermal gel and the preparation method thereof
10/28/2009CN101564376A Decoquinate solid dispersoid and preparation method thereof
10/28/2009CN101564374A Medicinal in situ forming eye gel
10/28/2009CN101564214A Cabin-type therapeutic shoes
10/28/2009CN101564160A Food for preventing and treating hyperlipemia and hyperglycemia and preparation method thereof
10/28/2009CN100554966C A screening method
10/28/2009CN100554963C Diagnostic markers for ischemia
10/28/2009CN100554326C Immune polysaccharide of rhizome of manyflower solomonseal, composition and application
10/28/2009CN100554281C Modified gum arabic
10/28/2009CN100554273C Derivative of organic phosphorus of containing structure of spirocyclic / cyclopropane, preparation method and application
10/28/2009CN100554270C Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/28/2009CN100554267C Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure
10/28/2009CN100554266C Aryl piperazine modified benzo [b] thiophene compound, and its preparing method and use
10/28/2009CN100554265C N-(4-bromo-2- fluorobenzene)-6-methox-7-[2(1H-1,2,3-1- triazole) ethoxy]-4-quinazoline amine hydrochloric acid synthesis and uses
10/28/2009CN100554264C Pyrazolyl and imidazolyl pyrimidines
10/28/2009CN100554263C Novel method of producing strontium ranelate heptahydrate
10/28/2009CN100554259C 2-benzo(C) foroxone compound, its production and use
10/28/2009CN100554257C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
10/28/2009CN100554255C Benzoisoselenothiazolidone derivatives and their preparing process and use
10/28/2009CN100554247C Muscarinic agonists
10/28/2009CN100554245C Processes for the preparation of 4- 4- 4-(2 -cyanoethenyl)-2,6-dimethylphenyl )amino) -2-pyrimidinyl)amino benzonitrile
10/28/2009CN100554244C New mao-b inhibitors
10/28/2009CN100553681C Chloromycetin solution for eye and preparation method thereof
10/28/2009CN100553679C Chloromycetin solution for eye and preparation method thereof
10/28/2009CN100553677C Drugs for treating vascular diseases
10/28/2009CN100553676C H9 sub-type fowl-flu HI stabilized antigen
10/28/2009CN100553672C Freeze-dried powder injection for injection for brain refreshment and its preparing method
10/28/2009CN100553658C Medication for treating dementia and preparation method
10/28/2009CN100553654C Ointment for treating burn and scald and preparation method thereof
10/28/2009CN100553649C A composition for regulating intestinal canal flora and improving hypoxia tolerance as well as its preparation method
10/28/2009CN100553642C Medicine and food dual purpose nutritive product for preventing and treating night blindness and its manufacturing method
10/28/2009CN100553641C Use of pachycladous algal onychin
10/28/2009CN100553640C Novel method for externally applied glucosamine for the treatment of arthritis and externally applied formulation of glucosamine
10/28/2009CN100553639C Boronic acid polyvalent salts for treating thrombosis
10/28/2009CN100553638C Application of alisol B23-mono acetic ester and alisma rhizome extract in reversal of cancer cell multi-drug tolerance
10/28/2009CN100553637C Hormone composition
10/28/2009CN100553636C Method of using diketopiperazines and composition containing them
10/28/2009CN100553635C Pharmaceutical composition containing amoxicillin, ambroxol and beta lactamase inhibitor and uses thereof
10/28/2009CN100553634C Epothilone derivatives for the treatment of multiple myeloma
10/28/2009CN100553633C Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
10/28/2009CN100553632C Composition for improving skin, hair and coat health containing flavanone
10/28/2009CN100553631C Pharmaceutical uses of 4-fluoro-N-(1,2- hydrindenl-2-yl) benzamide
10/28/2009CN100553630C Controlled release formulation for oral administration of metformin
10/28/2009CN100553629C Pharmaceutical use of paeonol for anti-esophageal cancer
10/28/2009CN100553628C Use of 2-bromo-isovanillin in preparing anti-cancer and/or anti-radiation, chemical therapy sensitivity-enhancing medicines
10/28/2009CN100553627C Externally applied medicine liquid and medicine powder for treating recurrent aphtha
10/28/2009CN100553626C A caffeine micro capsule and preparation method thereof
10/28/2009CN100553625C Oral suspension of active principle microcapsules
10/28/2009CN100553622C An enteric coated mini-pill of pantoprazole sodium
10/28/2009CN100553620C Medication for treating obstruction of qi in the chest
10/28/2009CN100553619C Medication for treating coronary heart disease and angina
10/28/2009CN100553618C Medication for treating toothache
10/28/2009CN100553617C Medicine for treating chest stuffiness and pains
10/28/2009CN100553615C Medication for treating cardiovascular and cerebrovascular diseases
10/27/2009US7610153 Multi-drug titration and evaluation
10/27/2009US7608737 N-(2-(7-(methoxy-d3)-naphthalen-1-yl)ethyl)acetamide-d3, a deuterated derivative of Agomelatine; side effect reduction; decreased metabolic liability; pharmakinetics; bioavailability;antidepressants; anxiolytic agents; bipolar disorders; dual melatoninergic agonist and serotoninergic antagonist
10/27/2009US7608726 Substituted indolepyridinium as anti-infective compounds
10/27/2009US7608725 Making 2-nitroimidazoles involving the selective nitration of N-substituted imidazoles which does not use a non-acidic alkyl nitrate; using potassium nitrate and trifluotoacetic anhydride to generate trifluoroacetyl nitrate in situ; cost efficiency; environmetally friendly; efficiency; antihypoxic
10/27/2009US7608724 Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines
10/27/2009US7608723 Indole and benzimidazole derivatives
10/27/2009US7608721 2-{4-[Ethyl-(thiazol-4-ylmethyl)-amino]-phenyl}-1,1,1,3,3,3-hexafluoro-propan-2-ol; liver-X-receptor modulators; anticholesterol agents; antiinflammatory agents; atherosclerosis; dyslipidemia; antidiabetic agents; alzheimer's disease; sepsis; skin disorders; cognition modulators
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608717 3-[2-(dimethylamino)ethyl]-1-[(3-fluorophenyl)sulfonyl]-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one; anxiety disorder or a cognitive disorder; central nervous system disorders; psychological disorders; neurodegenerative disorder; attention deficit disorder; obsessive compulsive disorder; Alzheimer's
10/27/2009US7608716 Pyrazolonaphthyridine derivative
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608687 Releasable linkage and compositions containing same
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608674 Therapy for kidney diseasel removal phosphates; gastrointestinal disorders
10/27/2009US7608643 Compounds for inhibiting KSP kinesin activity
10/27/2009US7608642 Wound and skin care compositions
10/27/2009US7608641 Creatine oral supplementation using creatine hydrochloride salt
10/27/2009US7608640 Curative and preventive activity in the pathogenesis of thrombo-embolic and haemostatic diseases of arterial or venous origin
10/27/2009US7608639 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608637 Prevention and treatment of bone disorders with EP4 agonistfor compounds posessing prostaglandins structure
10/27/2009US7608636 Medicines for treatment and prevention of neurogenic pain
10/27/2009US7608635 Pyrazole compounds that modulate HSP90 activity
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608630 Marasmius androsaceus L.es Fr extract, piperidone derivative, and their use for the preparation of hypertensives
10/27/2009US7608629 Useful for the treatment of migraine and other 5-HT1F receptor associated disorders; for example, N-[3-(1-methyl-piperidin-4-yloxy)-phenyl]-2-furancarboxamide
10/27/2009US7608628 Alkylsulphonamide quinolines
10/27/2009US7608627 6-azaindole compound
10/27/2009US7608626 2-(3-ethyl-2-phenylindolizin-1-yl)ethylamine; 2-(1,2,3,4-tetrahydropyrido[1,2-a]indol-10-yl)ethylamine; 2-(1,2,3,4-tetrahydropyrido[1,2-a]indol-10-yl)ethylamine; agonists of the 2C subtype of brain serotonin receptors; useful to treat a variety of central nervous system disorders such as schizophrenia
10/27/2009US7608625 Method for treating bruxism and bruxism-related diseases
10/27/2009US7608624 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
10/27/2009US7608623 N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonylpiperazinium hydrogen sulfate; N- alpha -(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyguanidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide; urokinase plasminogen activator inhibitor; anticarcinogenic agent
10/27/2009US7608622 1 -Phenylerhyl)-6-(3,4,5-trimethoxyphenyl)- 1 ,3-dihydroimidazo[4,5-b]pyrazin-2-one;
10/27/2009US7608621 Such as n-{[2-[(4-bromo-2-fluorophenyl)methyl]-5-hydroxy-6-(1-methylethyl)-3-oxo-2,3-dihydro-4-pyridazinyl]carbonyl}glycine; anemia; increasing erythropoietin production
1 ... 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 ... 7860